124 related articles for article (PubMed ID: 22370788)
1. Anti-glioma effect and safety of docetaxel-loaded nanoemulsion.
Gaoe H; Pang Z; Pan S; Cao S; Yang Z; Chen C; Jiang X
Arch Pharm Res; 2012 Feb; 35(2):333-41. PubMed ID: 22370788
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
[TBL] [Abstract][Full Text] [Related]
3. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
[TBL] [Abstract][Full Text] [Related]
4. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
[TBL] [Abstract][Full Text] [Related]
5. Preparation,-Characterization and Anti-Glioma Effects of Docetaxel-Incorporated Albumin-Lipid Nanoparticles.
Gao H; Cao S; Yang Z; Zhang S; Zhang Q; Jiang X
J Biomed Nanotechnol; 2015 Dec; 11(12):2137-47. PubMed ID: 26510308
[TBL] [Abstract][Full Text] [Related]
6. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
8. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals.
Li X; Du L; Wang C; Liu Y; Mei X; Jin Y
Pharmazie; 2011 Jul; 66(7):479-83. PubMed ID: 21812321
[TBL] [Abstract][Full Text] [Related]
10. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.
Najlah M; Kadam A; Wan KW; Ahmed W; Taylor KM; Elhissi AM
Int J Pharm; 2016 Jun; 506(1-2):102-9. PubMed ID: 27107899
[TBL] [Abstract][Full Text] [Related]
11. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
12. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
13. Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.
Gao H; Yang Z; Cao S; Xi Z; Zhang S; Pang Z; Jiang X
Nanotechnology; 2012 Nov; 23(43):435101. PubMed ID: 23060604
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
15. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
Li L; Tang F; Liu H; Liu T; Hao N; Chen D; Teng X; He J
ACS Nano; 2010 Nov; 4(11):6874-82. PubMed ID: 20973487
[TBL] [Abstract][Full Text] [Related]
16. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
[TBL] [Abstract][Full Text] [Related]
17. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy.
Oh KS; Lee H; Kim JY; Koo EJ; Lee EH; Park JH; Kim SY; Kim K; Kwon IC; Yuk SH
J Control Release; 2013 Jan; 165(1):9-15. PubMed ID: 23103984
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z
Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217
[TBL] [Abstract][Full Text] [Related]
19. Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
Yoo GH; Subramanian G; Piechocki MP; Ensley JF; Kucuk O; Tulunay OE; Lonardo F; Kim H; Won J; Stevens T; Lin HS
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):735-42. PubMed ID: 18645124
[TBL] [Abstract][Full Text] [Related]
20. Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas.
Fang JH; Lai YH; Chiu TL; Chen YY; Hu SH; Chen SY
Adv Healthc Mater; 2014 Aug; 3(8):1250-60. PubMed ID: 24623647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
